Trident II Tritanium Outcomes Study
ClinicalTrials.gov NCT02999009
Research payments
$735,063
Through program year 2025, $735,063 in research payments was reported against Trident II Tritanium Outcomes Study, across 273 payments, paid by Stryker Corporation.
- Paid by
- Stryker Corporation
- ClinicalTrials.gov
- NCT02999009
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $19,083 | 22 |
| 2024 | Research | $54,364 | 26 |
| 2023 | Research | $37,733 | 24 |
| 2022 | Research | $112,646 | 46 |
| 2021 | Research | $94,951 | 35 |
| 2020 | Research | $166,809 | 77 |
| 2019 | Research | $249,477 | 43 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Masini Ypsilanti, MI Named on 50 payments
- Benjamin Domb Des Plaines, IL Named on 42 payments
- Jason Oh New York, NY Named on 29 payments
- Geoffrey Westrich New York, NY Named on 28 payments
- Alvin Ong Egg Harbor Township, NJ Named on 23 payments
- John Noble Lake Charles, LA Named on 16 payments
- Edward Petrow Tucson, AZ Named on 14 payments
- Daniel Delgaizo Chapel Hill, NC Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.